Guangzhou Baiyunshan Pharmaceutical Co., (SZSE:000522) EBIT : ¥434 Mil (TTM As of Dec. 2012)

Guangzhou Baiyunshan Pharmaceutical Co., EBIT Chart

Guangzhou Baiyunshan Pharmaceutical Co., Annual Data
	Trend	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
EBIT		Get a 7-Day Free Trial					72.98	84.72	238.51	314.06	434.21

Guangzhou Baiyunshan Pharmaceutical Co., Quarterly Data
	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12
EBIT	Get a 7-Day Free Trial															55.71	119.09	151.12	74.79	89.20

Competitive Comparison of Guangzhou Baiyunshan Pharmaceutical Co.,'s EBIT

For the Drug Manufacturers - General subindustry, Guangzhou Baiyunshan Pharmaceutical Co.,'s EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangzhou Baiyunshan Pharmaceutical Co.,'s EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Co.,'s EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Co.,'s EV-to-EBIT falls into.

Guangzhou Baiyunshan Pharmaceutical Co., EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥434 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Co.,  (SZSE:000522) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Guangzhou Baiyunshan Pharmaceutical Co.,'s annualized ROC % for the quarter that ended in Dec. 2012 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2012) data.

2. Joel Greenblatt's definition of Return on Capital:

Guangzhou Baiyunshan Pharmaceutical Co.,'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2012 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2012) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Guangzhou Baiyunshan Pharmaceutical Co.,'s Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Co., EBIT Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Co.,'s EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangzhou Baiyunshan Pharmaceutical Co., Business Description